John Wiley & Sons (FRA:2F7) YoY EBITDA Growth: -35.56% (As of Jul. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2F7 John Wiley & Sons Inc FRA:2F7
54 GF Score
Price €40.80
GF Value €34.18
! 8 Warning Signs
View Full Analysis

What is John Wiley & Sons YoY EBITDA Growth?

John Wiley & Sons FRA:2F7 -0.49% 54 YoY EBITDA Growth is -35.56% as of Jul. 2026. GuruFocus rates FRA:2F7 with a GF Score™ of 54/100 and a GF Value™ of €34.18. The stock has 8 warning signs investors should review.

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. John Wiley & Sons's YoY EBITDA Growth for the quarter that ended in Jul. 2026 was -35.56%.

John Wiley & Sons's EBITDA per Share for the three months ended in Jul. 2026 was €0.67.

John Wiley & Sons YoY EBITDA Growth Historical Data

* Premium members only.

The historical data trend for John Wiley & Sons's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

John Wiley & Sons YoY EBITDA Growth Chart

John Wiley & Sons Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.55 -36.62 -85.23 719.09 16.64

John Wiley & Sons Quarterly Data
Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26 Jul26
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.46 1.13 19.29 40.66 -35.56
FRA:2F7
54GF Score
John Wiley & Sons Inc FRA:2F7
YoY EBITDA Growth is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

John Wiley & Sons YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

John Wiley & Sons's YoY EBITDA Growth for the fiscal year that ended in Apr. 2026 is calculated as:

YoY EBITDA Growth (A: Apr. 2026 )
=(EBITDA per Share (A: Apr. 2026 )-EBITDA per Share (A: Apr. 2025 ))/ | EBITDA per Share (A: Apr. 2025 ) |
=(6.506-5.578)/ | 5.578 |
=16.64 %

John Wiley & Sons's YoY EBITDA Growth for the quarter that ended in Jul. 2026 is calculated as:

YoY EBITDA Growth (Q: Jul. 2026 )
=(EBITDA per Share (Q: Jul. 2026 )-EBITDA per Share (Q: Jul. 2025 )) / | EBITDA per Share (Q: Jul. 2025 )) |
=(0.667-1.035)/ | 1.035 |
=-35.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about YoY EBITDA Growth →
What does a YoY EBITDA Growth of -35.56% mean?
John Wiley & Sons (FRA:2F7) has a YoY EBITDA Growth of -35.56% as of Jul. 2026. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for John Wiley & Sons and its competitors.
Is John Wiley & Sons' YoY EBITDA Growth too high?
John Wiley & Sons' current YoY EBITDA Growth is -35.56%. Overall, John Wiley & Sons has a GF Score™ of 54/100, reflecting its overall financial health beyond just this single metric.
How does John Wiley & Sons' YoY EBITDA Growth compare to TDAY and SCHL?
John Wiley & Sons' YoY EBITDA Growth of -35.56% can be compared against companies in the Media - Diversified industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good YoY EBITDA Growth for a Media - Diversified company?
A good YoY EBITDA Growth depends on the Media - Diversified industry context. However, YoY EBITDA Growth should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high YoY EBITDA Growth mean?
A high YoY EBITDA Growth can signal that a stock is expensive relative to its fundamentals. YoY EBITDA Growth is the percentage change of EBITDA per share over the past 12-month. View historical data for John Wiley & Sons and its competitors. John Wiley & Sons's current YoY EBITDA Growth is -35.56%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is John Wiley & Sons stock overvalued right now?
John Wiley & Sons (FRA:2F7) has a current YoY EBITDA Growth of -35.56%. The stock's GF Value™ is €34.18, compared to a current price of €40.80 — trading 19.4% above its estimated fair value. The current YoY EBITDA Growth is -35.56%. John Wiley & Sons' overall GF Score™ is 54/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is YoY EBITDA Growth calculated?
YoY EBITDA Growth is calculated from a company's financial statements. For John Wiley & Sons (FRA:2F7), the current YoY EBITDA Growth is -35.56% as of Jul. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is John Wiley & Sons (FRA:2F7) Overvalued in 2026?

Based on GuruFocus' analysis, John Wiley & Sons stock appears to be overvalued. The current stock price of €40.80 is trading 19.4% above its estimated GF Value™ of €34.18.

Key valuation signals for FRA:2F7:

  • YoY EBITDA Growth: -35.56%
  • GF Value™: €34.18 vs. price of €40.80 (19.4% above fair value)
  • GF Score™: 54/100 with 8 warning signs

No single metric tells the full story. See the FRA:2F7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

John Wiley & Sons Business Description

Address 111 River Street, Hoboken, NJ, USA, 07030
John Wiley & Sons Inc is a publisher and a trusted leader in research and learning. The company segment includes: Research, which includes the reporting lines of Research Publishing and Research Solutions, and Learning includes the Academic and Professional reporting lines and consists of publishing, courseware, and assessments. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.
54GF Score

Get the complete analysis for FRA:2F7

YoY EBITDA Growth is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€40.80
Price
€34.18
GF Value